Indium In 111 Oxyquinoline

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 72536-0920
  • Package NDC 72536-0920-1
  • Application number ANDA202586
  • SPL ID 0864f662-e3ce-4426-8c3c-e318f755a89d
  • SPL set ID 7dbfc0f9-0e2e-4aed-85bd-32cf7c74d402
  • UNII LGX9OL562T

What the source publishes

Labeler
BWXT Medical Ltd.
Active ingredients
Indium In-111 Oxyquinoline
Form
LIQUID
Routes
INTRAVENOUS
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:72536-0920_0864f662-e3ce-4426-8c3c-e318f755a89d
{
  "name": "Indium In 111 Oxyquinoline",
  "splId": "0864f662-e3ce-4426-8c3c-e318f755a89d",
  "labels": [
    {
      "setId": "7dbfc0f9-0e2e-4aed-85bd-32cf7c74d402",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7dbfc0f9-0e2e-4aed-85bd-32cf7c74d402",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7dbfc0f9-0e2e-4aed-85bd-32cf7c74d402"
    }
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "labeler": "BWXT Medical Ltd.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 mL in 1 VIAL, SINGLE-DOSE (72536-0920-1)",
      "package_ndc": "72536-0920-1",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20190927"
    }
  ],
  "productId": "72536-0920_0864f662-e3ce-4426-8c3c-e318f755a89d",
  "useDomain": "unknown",
  "dosageForm": "LIQUID",
  "productNdc": "72536-0920",
  "deaSchedule": null,
  "genericName": "Indium In-111 Oxyquinoline",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "INDIUM IN-111 OXYQUINOLINE",
      "strength": "1 mCi/mL"
    }
  ],
  "applicationNumber": "ANDA202586",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20190927",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000177914",
      "N0000000205"
    ],
    "unii": [
      "LGX9OL562T"
    ],
    "spl_set_id": [
      "7dbfc0f9-0e2e-4aed-85bd-32cf7c74d402"
    ],
    "pharm_class_epc": [
      "Radioactive Diagnostic Agent [EPC]"
    ],
    "pharm_class_moa": [
      "Radiopharmaceutical Activity [MoA]"
    ],
    "manufacturer_name": [
      "BWXT Medical Ltd."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:72536-0920_0864f662-e3ce-4426-8c3c-e318f755a89d"